6,678 trials
Atherosclerotic Cardiovascular Disease
Primary: Platelet Reactivity Defined by VerifyNow PRU in HPR and NPR Patients — 219; 241; 141; 159 PRU — p=0.169
Epilepsy, Idiopathic Generalized
Primary: Time to First Seizure — 169; 178 Days
Bipolar Disorder · Medication Adherence · Medication Non Adherence
Primary: Change in Tablets Routine Questionnaire (TRQ, Past Week) — 50.1; 37.5; 16.9 percentage of missed BD medications — p=<0.001
Human Immunodeficiency Virus · Smoking
Primary: Number of Participants Who Participate in the Post-treatment Interview — 9 Participants
Eosinophilia · Hypereosinophilic Syndrome · Leukocyte Disorder
Primary: Mean Percent Change in Eosinophil Count After Glucocorticoid Challenge — -69.6; -13.6 percentage of eosinophil count
Multiple Sclerosis (MS)
Primary: Annualized Relapse Rate (ARR) From the Time of Cessation of Natalizumab Treatment. — 0 number of relapses in a year
Hepatitis B Vaccine
Primary: Anti-HBs Seroconversion Rate at Month 7 — 118; 132 Participants
Hepatitis B, Chronic
Primary: Incidence Rate of Newly Diagnosed Hepatocellular Carcinoma (HCC) at Week 240 — 6.045 Events per person-year
Prostate Cancer Metastatic
Primary: Radiographic Progression-Free Survival (rPFS) — 8.0; 3.7 months — p=<0.0001
Dystocia
Primary: Number of Participants Delivered by Cesarean — 73; 72 Participants
Diabetes Mellitus Type 2
Primary: Effect of Androgel Treatment on Relative Nuclear Factor kB Activity Compared to Placebo — 100; 100; 100; 236 Percent change from baseline
Diabetes Mellitus, Type II
Primary: Number of Individual Plasma Proteins That Changed From Baseline to End-point Based on Limma T-Test of Protein Abundance as Determined by Proteomic Analysis Via Liquid…
ADHD
Primary: Parent ADHD Total Symptom Scores — 36.2; 34.6; 17.6; 15.3 score on a scale — p=0.55
Heart Failure With Preserved Ejection Fraction
Primary: Change in Plasma N-terminal Proatrial Natriuretic Peptide (NT proANP) — 47.4; 46.4 pg/mL
Shoulder Pain
Primary: Opioid Utilization — 54.79; 30.38 Morphine Milligram Equivalents (MME)